lobby

Pages

 

CEO welcomes the very strongly worded final ruling by European Ombudsman Emily O'Reilly in her inquiry into the Commission's implementation of UN rules for contacts with tobacco industry lobbyists.

Ahead of the Commission's proposal for a new ‘mandatory’ lobby transparency register, CEO takes a look at the summary of the public consultation on the subject: civil society's call for better transparency systems faces the spin of corporate lobby groups and trade associations, which appear to promote transparency values but recommend limited implementation, loopholes and toothless management.

In the run up to the UK referendum on EU membership on 23 June, Corporate Europe Observatory has tabled a series of freedom of information requests to find out how UK finance lobbies have been influencing the referendum negotiations and the Capital Markets Union. But the Brexit-Bremain referendum seems to be a freedom of information black hole.

You have probably never heard of AMISA2. But it turns out that AMISA2 and its predecessor AMISA have had staggeringly regular high-level access to senior EU decision-makers for decades. It is a quiet but persistent presence operating in the shadows of the Brussels bubble.

Subscribe to our newsletter

CEO welcomes the very strongly worded final ruling by European Ombudsman Emily O'Reilly in her inquiry into the Commission's implementation of UN rules for contacts with tobacco industry lobbyists.

CEO joined forces with nine other civil society organisations working for equality, non-discrimination, transparent decision-making and strong ethics rules: in an open letter to the European Parliament we urge MEPs to oppose Oettinger’s appointment as the Comission’s head of human resources.

After nine months of hearings, the draft report of the EU Parliament's inquiry into the Dieselgate scandal has it black on white: the European Commission and EU member states had known since 2004-05 that diesel cars' nitrogen oxide emissions were far above legal limits - yet neither took action.

Our new report shows how industry lobbies present employee protection against work-related cancers as an 'unnecessary' burden on companies, and explains which tactics have been used to weaken and delay the European Union's revision of the Carcinogens and Mutagens Directive.